Abiopharma

Investor Alert: Robbins LLP Informs Investors of the LifeMD, Inc. Class Action Lawsuit

Notification from CEL SCI CORP

Q & M Dental Group (Singapore) Limited - Announcement

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

New Form 144/A - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000015 Size: 6 KB

New Form 144/A - Fulgent Genetics, Inc. Filed: 2025-08-27 AccNo: 0001819718-25-000016 Size: 6 KB

Ryan Jason 🔴 sold 39.2K shares of GeneDx Holdings Corp. (WGS) at $130.01 ($5.0M) Transaction Date: Aug 27, 2025 | Filing ID: 023190

Dizon Romeo R 🟢 acquired 1.0K shares of IRIDEX CORP (IRIX) at $1.30 Transaction Date: Aug 27, 2025 | Filing ID: 111774

Bjork Elisabeth 🟢 acquired 10.0K shares of ROCKET PHARMACEUTICALS, INC. (RCKT) at $3.41 Transaction Date: Aug 27, 2025 | Filing ID: 033017